Alisa Molotova

SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London.

Marmalade Technologies Ltd. provides cross-platform software development kit and game engine services. Its products include Marmalade SDK enables developers to deploy code across multiple platforms and devices from a single code base in C++, Lua, HTML or Objective-C; Marmalade Juice a new tool that lets customer port an existing Objective-C codebase to Android; Marmalade Quick provides a fast, flexible and open RAD environment that lets customer use Lua and Cocos2d-x to build 2d games; and Web Marmalade supports the creation of hybrid apps, using HTML5, CSS and JavaScript and packaged as native app installers, ready for deployment to the relevant app stores. The company was founded by Edward David Gilchrist, Eben Upton and Bruce Nick Beckloff in 1998 and is headquartered in London, the United Kingdom.

Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology.

Marshall of Cambridge (Holdings) Ltd. engages in aerospace engineering, military and land systems engineering, motor retail and leasing activities. The firm operates through Aerospace and Defence Group, Property and Fleet Solutions segments. The company was founded by David Gregory Marshall on October 1, 1909 and is headquartered in Cambridge, the United Kingdom.

Endemol UK Ltd. produces entertainment programs as a non-broadcaster through a variety of communication mediums. The company was founded in 1983 and is headquartered in London, the United Kingdom.

EEF Ltd. operates a trade association for engineering and manufacturing industries. It business support services cover human resources and employment law, productivity improvement, research and intelligence, health, safety and environmental issues. The firm helps foster enterprise and innovation while making sure businesses are compliant, competitive, and future-focused. The company was founded in 1896 and is headquartered in London, the United Kingdom.

CyanConnode Ltd. engages in the development, marketing, and sale of an integrated system and software design delivering mesh based wireless solutions for utility metering and lighting control. The company was founded on April 6, 2003 and is headquartered in Cambridge, the United Kingdom.

The Cambridge Angels (Cambridge Angels) is a venture capital firm founded in 1999 by Robert Sansom, David Cleevely and Doug Richard. The firm is headquartered in London, United Kingdom.

Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.

Part of Moore Stephens International Ltd., Shine Wing Pty Ltd. is an Australian company.

Forte Medical Ltd. operates as a specimen collection company. It manufactures and sells medtech devices. The company was founded by Vincent John Charles Forte and Giovanna Forte and is headquartered in London, the United Kingdom.

UltraShape redefines aesthetic medicine by developing, manufacturing and marketing innovative non-invasive technologies for fat cell destruction and body sculpting. The company develops and markets clinically proven safe and effective solutions that enhance the lives of patients. The UltraShape proprietary technology employs pulsed (non-thermal) focused ultrasound that instantly, selectively and permanently destroys fat cells without affecting surrounding structures. Founded in 2000, UltraShape has sold Contour I devices in more than 50 countries, demonstrating safety and efficacy. The UltraShape Contour I system, is authorized for marketing outside the U.S. It is the first clinically proven non-invasive solution that offers measurable lasting body sculpting results for men and women with no need for maintenance treatments. The UltraShape system has been shown to be safe and effective in a multi-center controlled trial and numerous other peer-reviewed published independent clinical studies. The device is designed to produce mechanical, non-thermal, acoustic effects which target and selectively destroy (breakdown) fat cells, leaving surrounding critical structures such as skin, blood vessels, nerves, and connective tissue intact. The latest Contour I V3 system uses Vertical Dynamic Focus™ (VDF) pulsed (non-thermal) focused ultrasound that instantly and permanently destroys fat cells providing patients a convenient noninvasive no-downtime solution to reduce localized fat deposits and body circumference. The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the destroyed fat cells are processed by the body's natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape's peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver. Over 200,000 patient treatments have been performed worldwide with the Contour I showing high patient satisfaction while demonstrating safety and efficacy. The UltraShape procedure is guided by proprietary real-time tracking and guidance technology designed to deliver smooth, uniform body contouring results. The software guides the operator through a pres-determined treatment algorithm designed to minimize risk of contour irregularities, a common side effect of invasive and non-invasive procedures. The UltraShape procedure is performed during a convenient, 'walk-in, walk-out' session carried out in an office-based environment; it requires no anesthesia or sedation. After treatment, patients immediately resume their daily routines with no need for maintenance treatments. The UltraShape Contour I received the CE Mark in 2005 and a medical device license from Health Canada in 2007. The Contour I system is not available for sale in the U.S; the Contour Plus system is an investigational product limited by U.S. law to investigational use only.

Capital for Enterprise Fund Managers Ltd is a private equity firm founded in 2008. The firm is headquartered in the UK.

Weizmann UK is a non-profit company that operates scientific research institutes. The company is based in London, UK. The British company was founded in 1950.

Audio Analytic Ltd. produces sound recognition and analysis software. The firm offers ai3 which recognizes a number of sounds from window glass break, dog bark, smoke and CO alarm, baby cry to anomaly detection. The company was founded by Christopher Mitchell in 2010 and is headquartered in Cambridge, the United Kingdom.

Arachnys Information Services Ltd. provides a business data information processing platform. It specializes in compliance, onboarding, KYC, and due diligence solutions. The company was founded by David Buxton and Harry Waye in 2010 and is headquartered in London, the United Kingdom.

Plumis Ltd. produces fire protection products for domestic environments. Its product Automist; a simple, retrofittable, sprinkler-alternative for full room active fire protection. In the event of a fire, the system is triggered automatically by a ceiling mounted detector. The company was founded by William Makant, Alan Hart, and Yusuf Muhammad in 2008 and is headquartered in London, the United Kingdom.

UK Business Angels Association provides investment solutions. It engages in the national trade association representing angel and early stage investment. The firm also connects to all those involved in the angel investment market with a view to ensuring a coherent ecosystem for financing the growth of start-up and early stage businesses. The company is headquartered in London, the United Kingdom.

Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom.

Octagon I/O Ltd. provides software services. It is a combination of hardware and software that provides an end-to-end solution for the collection, storage and analysis of sensor data. The company was founded by Raphael Scheps and Gideon Farrell in 2014 is headquartered in London, the United Kingdom.

Vantage Power Ltd. manufactures retrofit table hybrid double dicker bus engines. Its products and solutions include VPVision, HEV drive, Range Extender, and custom battery solutions. The company was founded by Alexander Schey and Toby Schulz in 2011 and is headquartered in Greenford, the United Kingdom.

Zeetta Networks Ltd. develops marketing open platform networking solutions. Its flagship product, NetOS, a Network Operating System which offers a "USB-like", plug-n-play management of all connected network devices and enables the construction of virtual “network slices” for the deployment of B2B or B2C services such as Ultra-HD video distribution, City-wide Wi-Fi, Internet of Things (IoT) and M2M deployments. The company was founded by Reza Nejabati, Vassilis Seferidis, Mayur Channegowda and Dimitra Simeonidou and is headquartered in Bristol, the United Kingdom.

LGGP Holdings Ltd (Accelerated Digital Ventures) is a venture capital subsidiary of Legal & General Group Plc founded in 2016 by Lee Strafford, Michael Dimelow, David Carr, David Fogel and Andrew Sloane. The firm is headquartered in London, United Kingdom with additional office in Palo Alto.

Tether Technology Ltd. provides security services. It offers platform for managing all physical security devices and locations. The firm serves the retail and restaurant, housing accessories, healthcare, cctv rental, and ATM security. The company was founded by Roman Gaufman and Regina Shmerlin on August 4, 2009 and is headquartered in London, the United Kingdom.

Metaboards Ltd. manufactures magneto devices and develops software application. It specializes in medical devices, consumer electronics, aerospace and defence, clothing and fabrics. The company was founded by Ekaterina Shamonina and is headquartered in Oxford, the United Kingdom.

YellowDog Ltd. develops and operates software application for animation and VFX rendering. It provides platform for banking, engineering, and telco. The firm also provides financial services. The company was founded by Gareth Daniel Parry Williams on January 9, 2015 and is headquartered in Bristol, the United Kingdom.

Workfinder Ltd. provides different projects and placements for the graduates in United Kingdom. The company was founded on June 27, 2019 and is headquartered in London, the United Kingdom.

Evolution Artificial Intelligence Ltd. engages in the development of a language processing software application. It offers machine reading platform, invoice capture, and RPA integration solutions. The company was founded by Martin Goodson and Rafal Kwasny and is headquartered in London, the United Kingdom.

Paytia Ltd. specializes in telephone payment processing. The company was ffounded by Curtis Gregory Nash in 2016 and is headquartered in London, the United Kingdom.

GKMH Ltd. is a company based in Newmarket, UK. The British company was founded in 2019.

Boutros Bear Ltd. develops an evidenced-based healthcare platform. The company is based in Cambridge, UK. The British company was founded by Sheila Kissane, who has been the CEO since incorporation.

Health Technologies Ltd., operating under the name Qured, offers personalized employee health checks and screening to improve team health, satisfaction, and productivity. The company is based in London, UK. The British company's at-home blood tests are designed to help individuals live longer, healthier lives by testing for important health indicators such as organ function, fertility profile, and cancer warning signs. Qured's mission is to provide personalized healthcare for everyone, aided by digital technologies.

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov.